Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
People with advanced cancer are at heightened risk of desire for hastened death (DHD), suicidal ideation (SI), and completed suicide. Loss of Meaning (LoM), a component of demoralization, can be elevated by a cancer diagnosis and predicts DHD and SI in this population. We completed a randomized controlled trial in which psilocybin-assisted psychotherapy (PAP) produced rapid and sustained improvements in depression, demoralization, and hopelessness in people with cancer. Converging epidemiologic and clinical trial findings suggests a potential antisuicidal effect of this treatment. To probe our hypothesis that PAP relieves SI through its beneficial impacts on depression and demoralization (LoM in particular), we performed secondary analyses assessing within- and between-group differences with regard to LoM and an SI composite score. Among participants with elevated SI at baseline, PAP was associated with within-group reductions in SI that were apparent as early as 8 h and persisted for 6.5 months postdosing. PAP also produced large reductions in LoM from baseline that were apparent 2 weeks after treatment and remained significant and robust at the 6.5 month and 3.2 and 4.5 year follow-ups. Exploratory analyses support our hypothesis and suggest that PAP may be an effective antisuicidal intervention following a cancer diagnosis due to its positive impact on hopelessness and demoralization and its effects on meaning-making in particular. These preliminary results implicate psilocybin treatment as a potentially effective alternative to existing antidepressant medications in patients with cancer that are also suicidal, and warrant further investigation in participants with elevated levels of depression and suicidality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One of these shows a sustained reduction in demoralization, 62 while the other presents the clinical response rates for depression and anxiety. 61”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only two long-term 4.5-year follow-up studies are available, involving 4 and 14 patients, respectively. 61,62”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“with only two secondary analyses providing data on 4.5 years of follow-up, 61,62”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [62]
The cited source says what the claim attributes to it.
In the citing paper
“Open-label studies 25,39,57,78-81 and two followup analyses 61,62 supported the overall positive findings of RCTs.”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [62]
The cited source says what the claim attributes to it.
In the citing paper
“Secondary analyses of these data 4.5 years later found that psilocybin therapy was also associated with reductions in suicidal ideation that were apparent post-intervention and persisting as well as with large reductions in loss of meaning persisting up to 4.5 years”
From Psychosocial and Integrative Oncology: Interventions Across the Disease Trajectory. (2023) · cites this paper as Ross et al. 2021
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
World Health Organization classification of tumors
Kleihues, P., & Sobin, L. H. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2887::aid-cncr32>3.0.co;2-f · Cited by 2,377
Suicide and suicidal behaviour
Turecki, G., & Brent, D. A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00234-2 · Cited by 2,338
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Self-citationPsychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206
Depression, Hopelessness, and Desire for Hastened Death in Terminally Ill Patients With Cancer
Breitbart, W. (2000) · JAMA · doi:10.1001/jama.284.22.2907 · Cited by 1,110
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920
Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients
McClain, C. S., Rosenfeld, B., & Breitbart, W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13310-7 · Cited by 812
Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723
Semkovska, M., & McLoughlin, D. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.009 · Cited by 718
Wilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., Sos, P., Wang, G., Zarate, C. A., & Sanacora, G. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040472 · Cited by 696
Storch, E. A., Roberti, J. W., & Roth, D. A. (2004) · Depression and Anxiety · doi:10.1002/da.20002 · Cited by 694
Incidence of Suicide in Persons With Cancer
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8941 · Cited by 608
Price, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600
A Current Perspective of Suicide and Attempted Suicide
Mann, J. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00010 · Cited by 568
Breitbart, W., Rosenfeld, B., Pessin, H., Applebaum, A., Kulikowski, J., & Lichtenthal, W. G. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.2198 · Cited by 563
Antipsychotic medication in schizophrenia: a review
Lally, J., & MacCabe, J. H. (2015) · British Medical Bulletin · doi:10.1093/bmb/ldv017 · Cited by 513
The demoralization scale: a report of its development and preliminary validation
Kissane, D. W., Wein, S., Love, A., Lee, X. Q., Kee, P. L., & Clarke, D. M. (2004) · Journal of Palliative Care · doi:10.1177/082585970402000402 · Cited by 442
Robinson, S., Kissane, D. W., Brooker, J., & Burney, S. (2015) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2014.07.008 · Cited by 401
Spirituality, Religion, and Depression in the Terminally Ill
Nelson, C. J., Rosenfeld, B., Breitbart, W., & Galietta, M. (2002) · Psychosomatics · doi:10.1176/appi.psy.43.3.213 · Cited by 399
Breitbart, W., Pessin, H., Rosenfeld, B., Applebaum, A. J., Lichtenthal, W. G., Li, Y., Saracino, R. M., Marziliano, A. M., Masterson, M., Tobias, K., et al. (2018) · Cancer · doi:10.1002/cncr.31539 · Cited by 396
Composite Variables: When and How
Song, M.-K., Lin, F.-C., Ward, S. E., & Fine, J. P. (2013) · Nursing Research · doi:10.1097/nnr.0b013e3182741948 · Cited by 388
Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565653 · Cited by 381
Derogatis, L. R. (1993) · Medical Entomology and Zoology · Cited by 375
Depression, Hopelessness, and Suicidal Ideation in the Terminally Ill
Chochinov, H. M., Wilson, K. G., Enns, M., & Lander, S. (1998) · Psychosomatics · doi:10.1016/s0033-3182(98)71325-8 · Cited by 363
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360
Self-citationPrice, R. B., Iosifescu, D. V., Murrough, J. W., Chang, L. C., Al Jurdi, R. K., Iqbal, S. Z., Soleimani, L., Charney, D. S., Foulkes, A. L., & Mathew, S. J. (2014) · Depression and Anxiety · doi:10.1002/da.22253 · Cited by 345
Relief of Expressed Suicidal Intent by ECT: A Consortium for Research in ECT Study
Kellner, C. H., Fink, M., Knapp, R., Petrides, G., Husain, M., Rummans, T., Mueller, M., Bernstein, H., Rasmussen, K., O’Connor, K., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.977 · Cited by 345
Zaorsky, N. G., Zhang, Y., Tuanquin, L., Bluethmann, S. M., Park, H. S., & Chinchilli, V. M. (2019) · Nature Communications · doi:10.1038/s41467-018-08170-1 · Cited by 329
Bredle, J. M., Salsman, J. M., Debb, S. M., Arnold, B. J., & Cella, D. (2011) · Religions · doi:10.3390/rel2010077 · Cited by 324
Rodin, G., Lo, C., Mikulincer, M., Donner, A., Gagliese, L., & Zimmermann, C. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.10.037 · Cited by 323
Ballard, E. D., Ionescu, D. F., Vande Voort, J. L., Niciu, M. J., Richards, E. M., Luckenbaugh, D. A., Brutsché, N. E., Ameli, R., Furey, M. L., & Zarate, C. A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.027 · Cited by 286
Anderson, B. T., Danforth, A., Daroff, P. R., Stauffer, C., Ekman, E., Agin-Liebes, G., Trope, A., Boden, M. T., Dilley, P. J., Mitchell, J., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100538 · Cited by 284
Self-citationChochinov, H. M. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00456-9 · Cited by 271
Suicide Risk in Cancer Patients From 1960 to 1999
Hem, E., Loge, J. H., Haldorsen, T., & Ekeberg, Ø. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.052 · Cited by 252
LSD-Assisted Psychotherapy in Patients with Terminal Cancer
Grof, S., Goodman, L. E., Richards, W. A., & Kurland, A. A. (2017) · International Pharmacopsychiatry · doi:10.1159/000467984 · Cited by 209
Swift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., Guss, J., Bossis, A. P., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817715966 · Cited by 195
Self-citationRodríguez-Prat, A., Balaguer, A., Booth, A., & Monforte-Royo, C. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016659 · Cited by 180
The Desire for Hastened Death in Patients with Metastatic Cancer
Rodin, G., Zimmermann, C., Rydall, A., Jones, J., Shepherd, F. A., Moore, M., Fruh, M., Donner, A., & Gagliese, L. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.09.034 · Cited by 168
Rosenfeld, B., Breitbart, W., Stein, K., Funesti-Esch, J., Kaim, M., Krivo, S., & Galietta, M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.94 · Cited by 159
Factors associated with the wish to hasten death: a study of patients with terminal illness
Kelly, B. J., Burnett, P. C., Pelusi, D., Badger, S. J., Varghese, F. T. N., & Robertson, M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006827 · Cited by 153
(1969) · PubMed · Cited by 150
Rosenfeld, B. D., BREITBART, W. S., Galietta, M., Kaim, M., Funesti-Esch, J., Pessin, H., Nelson, C. J., & Brescia, R. J. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2868::aid-cncr30>3.0.co;2-k · Cited by 148
Study of Lysergic Acid Diethylamide as an Analgesic Agent
KAST, E. C., & COLLINS, V. J. (1964) · Anesthesia & Analgesia · doi:10.1213/00000539-196405000-00013 · Cited by 142
Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majić, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.012 · Cited by 122
Jones, J. M., Huggins, M. A., Rydall, A. C., & Rodin, G. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00526-9 · Cited by 111
Therapeutic Applications of Classic Hallucinogens
Bogenschutz, M. P., & Ross, S. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_464 · Cited by 109
Self-citationPsilocybin, psychological distress, and suicidality
Hendricks, P. S., Johnson, M. W., & Griffiths, R. R. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115598338 · Cited by 106
Zeifman, R. J., Wagner, A. C., Watts, R., Kettner, H., Mertens, L. J., & Carhart-Harris, R. L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00782 · Cited by 106
Self-citationTherapeutic use of classic psychedelics to treat cancer-related psychiatric distress
Ross, S. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1482261 · Cited by 102
Self-citationTerminally ill cancer patients' wish to hasten death
Kelly, B., Burnett, P., Pelusi, D., Badger, S., Varghese, F., & Robertson, M. (2002) · Palliative Medicine · doi:10.1191/0269216302pm538oa · Cited by 98
Cancer Diagnosis and Suicide Mortality: A Systematic Review and Meta-Analysis
Amiri, S., & Behnezhad, S. (2020) · Archives of Suicide Research · doi:10.1080/13811118.2019.1596182 · Cited by 98
Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide
Kast, E. (1967) · The Psychiatric Quarterly · doi:10.1007/bf01575629 · Cited by 94
Suicide among 915,303 Austrian cancer patients: Who is at risk?
Vyssoki, B., Gleiß, A., Rockett, I. R. H., Hackl, M., Leitner, B., Sonneck, G., & Kapusta, N. D. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.028 · Cited by 90
Suicide Rates and Risk Factors among Korean Cancer Patients, 1993-2005
Ahn, E., Shin, D. W., Cho, S.-I., Park, S., Won, Y.-J., & Yun, Y. H. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0261 · Cited by 89
The impact of Ayahuasca on suicidality: results from a randomized controlled trial
Zeifman, R. J., Palhano-Fontes, F., Hallak, J., Arcoverde, E., Maia-Oliveira, J. P., & Araujo, D. B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01325 · Cited by 87
Self-citationZeifman, R. J., Singhal, N., SANTOS, R. G. D., Sanches, R. F., Osório, F. D. L., Hallak, J. E. C., & Weissman, C. R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05692-9 · Cited by 87
Self-citationDeterminants of suicidal ideation in patients with breast cancer
Kim, J., Jang, J., Stewart, R. J., Kim, S., Kim, S., Kang, H., Shin, I., Park, M., Yoon, J., & Yoon, J. (2013) · Psycho-Oncology · doi:10.1002/pon.3367 · Cited by 75
High suicide mortality soon after diagnosis among cancer patients in central Italy
Crocetti, E., Arniani, S., Acciai, S., Barchielli, A., & Buiatti, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.199 · Cited by 70
Argento, E., Strathdee, S. A., Tupper, K. W., Braschel, M. C., Wood, E., & Shannon, K. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016025 · Cited by 68
Death Ideation in Cancer Patients: Contributing Factors
Madeira, N., Albuquerque, E., Santos, T., Mendes, A., & Roque, M. (2011) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2011.615381 · Cited by 64
Rosenfeld, B., Pessin, H., Lewis, C., Abbey, J., Olden, M., Sachs, E., Amakawa, L., Kolva, E., Brescia, R., & Breitbart, W. (2011) · Psychological Assessment · doi:10.1037/a0021767 · Cited by 61
Why Do Some Cancer Patients With Depression Desire an Early Death and Others Do Not?
Akechi, T., Okamura, H., Yamawaki, S., & Uchitomi, Y. (2001) · Psychosomatics · doi:10.1176/appi.psy.42.2.141 · Cited by 61
Hengartner, M. P., & Plöderl, M. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000501215 · Cited by 60
Recklitis, C. J., Zhou, E. S., Zwemer, E. K., Hu, J. C., & Kantoff, P. W. (2014) · Cancer · doi:10.1002/cncr.28880 · Cited by 59
Characterizing the course of suicidal ideation response to ketamine
Ballard, E. D., Yarrington, J. S., Farmer, C. A., Richards, E., Machado-Vieira, R., Kadriu, B., Niciu, M. J., Yuan, P., Park, L., & Zarate, C. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.077 · Cited by 55
Suicidality and its Associated Factors in Cancer Patients: Results of a Multi-Center Study in Korea
Shim, E.-J., & Park, J.-H. (2012) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.43.4.g · Cited by 48
Suicide in Cancer Patients in California, 1997–2006
Nasseri, K., Mills, P. K., Mirshahidi, H., & Moulton, L. H. (2012) · Archives of Suicide Research · doi:10.1080/13811118.2013.722056 · Cited by 48
Kawashima, Y., Yonemoto, N., Inagaki, M., Inoue, K., Kawanishi, C., & Yamada, M. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.07.003 · Cited by 48
Näslund, J., Hieronymus, F., Lisinski, A., Nilsson, S., & Eriksson, E. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2017.24 · Cited by 41
Psychiatric Pathology and Suicide Risk in Patients with Cancer
Costantini, A., Pompili, M., Innamorati, M., Zezza, M. C., Di Carlo, A., Sher, L., & Girardi, P. (2014) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2014.917136 · Cited by 40
Antisuicide Properties of Psychotropic Drugs: A Critical Review
Ernst, C. L., & Goldberg, J. F. (2004) · Harvard Review of Psychiatry · doi:10.1080/10673220490425924 · Cited by 32
Parpa, E., Tsilika, E., Galanos, A., Nikoloudi, M., & Mystakidou, K. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04715-2 · Cited by 29
Batterham, P. J., Calear, A. L., O’Dea, B., Larsen, M. E., J Kavanagh, D., Titov, N., March, S., Hickie, I., Teesson, M., Dear, B. F., et al. (2019) · DIGITAL HEALTH · doi:10.1177/2055207619878069 · Cited by 21
Clozapine: Key Discussion Points for Prescribers
Hill, M. B., & Freudenreich, O. (2013) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.hifr.01062013 · Cited by 18
Clozapine: promising treatment for suicidality in bipolar disorder.
Wilkowska, A., Wiglusz, M. S., & Cubała, W. J. (2019) · PubMed · Cited by 14
Research works printed but not linked: 2
- Robinson, 2015, A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research, J. Pain Symptom Manage., 49, 595, 10.1016/j.jpainsymman.2014.07.008 · DOI · Paper page
- Ross, 2021, Psilocybin
Cited by
Towards an understanding of psychedelic-induced neuroplasticity
Calder, A. E., & Hasler, G. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01389-z · Cited by 313
Yao, Y., Guo, D., Lu, T., Liu, F.-L., Huang, S., Diao, M.-Q., Li, S., Zhang, X.-J., Kosten, T. R., Shi, J., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115886 · Cited by 174
Demoralization in suicide: A systematic review
Costanza, A., Chytas, V., Ambrosetti, J., Shah, S., Amerio, A., Aguglia, A., Serafini, G., Piguet, V., Luthy, C., Cedraschi, C., et al. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.110788 · Cited by 142
Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis
Metaxa, A.-M., & Clarke, M. J. (2024) · BMJ · doi:10.1136/bmj-2023-078084 · Cited by 120
Livne, O., Shmulewitz, D., Walsh, C. A., & Hasin, D. S. (2022) · Addiction · doi:10.1111/add.15987 · Cited by 107
Metadata
- Authors
- Ross, S., Agin-Liebes, G., Lo, S., Zeifman, R. J., Ghazal, L., Benville, J., Franco Corso, S., Bjerre Real, C., Guss, J., Bossis, A., & Mennenga, S. E.
- Affiliations
- NYU Langone Health (US)
- San Francisco General Hospital (US)
- Pacific University Oregon (US)
- Toronto Metropolitan University (CA)
- Columbia University , , , , ,
- Memorial Sloan Kettering Cancer Center , , , ,
- Corresponding author
- Ross, Stephen
- Venue
- ACS Pharmacology & Translational Science
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-03-18
- Volume
- 4
- Issue
- 2
- Pages
- 553-562
- ISSN
- 2575-9108 (ISSN-L)
- PMC
- PMC8033770
- OpenAlex
- W3138429576
- Cited by
- 139
- References
- 80
- Citations by year
- 2026: 14 · 2025: 33 · 2024: 40 · 2023: 22 · 2022: 24 · 2021: 6
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- ACS Pharmacology & Translational Science (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Riverstyx Foundation
- Clinical and Translational Science Institute, New York University
- Heffter Research Institute
- National Institute on Drug Abuse (T32DA007294, T32DA007250)
- National Cancer Institute (P30CA008748)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- psilocybin-assisted therapy, suicidal ideation, meaninglessness, demoralization, advanced cancer, depression, hopelessness, meaning-making, psychedelic therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.